Medicine
Lokelma 10 g/10 g powder for oral suspension
Lokelma 10 g/10 g powder for oral suspension is a prescription medicine containing Sodium zirconium cyclosilicate for oral use, marketed by AstraZeneca Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store LOKELMA at 15°C-30°C (59°F-86°F).
Key facts
- Active ingredient (INN)
- Sodium zirconium cyclosilicate
- Brand
- Lokelma
- Strength
- 10 g/10 g
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 30 packets, 11 packets, 3 packets and 4 more
- Marketing authorisation holder
- AstraZeneca Pharmaceuticals
- Manufacturers
- AstraZeneca PharmaceuticalsA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store LOKELMA at 15°C-30°C (59°F-86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE10 Sodium zirconium cyclosilicate
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 4 September 2018
- Identifiers
- RxCUI 2047642, 2053927, 2047633 +1DailyMed set ID 8833d6e6-33ab-4ea9-b78f-3ec30a904ef8, 90bf8e28-748d-4e4b-a19f-9cf483370eff, 7f7ed64d-8480-4143-a207-29c24a0b9363NDC 50090-6501, 0310-1105, 0310-1110 +1Application NDA207078
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 packet in 1 box / 5 g in 1 packet | 0310-1105-30 | AstraZeneca Pharmaceuticals | 4 September 2018 |
| 11 packet in 1 box / 5 g in 1 packet | 0310-1105-39 | AstraZeneca Pharmaceuticals | 2 January 2019 |
| 30 packet in 1 box / 10 g in 1 packet | 0310-1110-30 | AstraZeneca Pharmaceuticals | 4 September 2018 |
| 11 packet in 1 box / 10 g in 1 packet | 0310-1110-39 | AstraZeneca Pharmaceuticals | 2 January 2019 |
| 30 packet in 1 box / 10 g in 1 packet | 50090-6501-0 | A-S Medication Solutions | 25 May 2023 |
| 3 packet in 1 bag / 10 g in 1 packet | 50090-6501-1 | A-S Medication Solutions | 7 June 2023 |
| 30 packet in 1 box / 5 g in 1 packet | 50090-6502-0 | A-S Medication Solutions | 25 May 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Sodium zirconium cyclosilicate is a prescription medicine indicated for the treatment of hyperkalemia in adults. It is available as powder for oral suspension. MedsAcross supplies Sodium zirconium cyclosilicate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium zirconium cyclosilicateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- LOKELMA prescribing information (AstraZeneca Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Lokelma: European public assessment report (EPAR) · European Medicines Agency
Need Lokelma 10 g/10 g powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.